CVE-2021-39369

Exploitation

Assessed, none found. CISA's assessment recorded neither public exploit code nor evidence of exploitation when it was made.

SSVC decision

• ExploitationnoneCISA recorded no public exploit code and no evidence of exploitation.
• AutomatablenoAt least one step from reconnaissance to exploitation cannot be reliably automated.
• Technical ImpactpartialSuccessful exploitation gives limited control of the vulnerable component.

CISA publishes the decision points, not a final SSVC decision. The decision also depends on mission and well-being impact, which is a property of your deployment rather than of the vulnerability.

EPSS probability

0.92% probability of exploitation activity in the next 30 days.

EPSS percentile

Equal to or higher than the score of 60.0% of scored records. A rank, not a probability.

NVD base score

6.5 (CVSS v3.x), scored by the NVD independently of the CNA.

NVD CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

NVD analysis status

Modified. NVD last modified this record on 2026-06-17.

Red Hat severity

No Red Hat rating. Red Hat rates the CVEs that affect its products.

Exploit-prediction scores from FIRST. Independent scoring and analysis status from the NVD. Vendor severity from Red Hat. Exploitation assessment and catalog membership from CISA.

Published

2022-12-26 00:00Z3 YR AGO

Last updated

2025-04-14 16:13Z1 YR AGO

Reserved

2021-08-22

Assigning CNA

mitre

Record state

PUBLISHED

Severity

Medium (CVSS 6.5)

CNA CVSS vector

CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N

Weaknesses

• CWE-22Improper Limitation of a Pathname to a Restricted Directory ('Path Traversal')Base

Data version

5.1

Document digest

83eeeafaa24fd3aedb4c6d7ba587a6b0d46ef7dab00283a9731ef22bb231bcc2

• www.youtube.comhttps://www.youtube.com/watch?v=7zC84TNpIxw
• www.usa.philips.comhttps://www.usa.philips.com/healthcare
• www.cisa.govhttps://www.cisa.gov/uscert/ics/advisories/icsma-21-187-01